Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07577505
NA

Histidine Supplementation for Antitumor Immunity in Colorectal Cancer

Sponsor: Jing-yuan Fang, MD, Ph. D

View on ClinicalTrials.gov

Summary

The goal of this clinical study is to learn whether oral histidine supplementation may be safely used to support antitumor immune function during standard colorectal cancer treatment. Participants with colorectal cancer in the supplementation group will: Take 2g oral histidine once daily during standard colorectal cancer treatment; Provide blood samples before and after supplementation; Attend regular follow-up visits for laboratory tests, safety assessment, and treatment evaluation.

Official title: A Single-arm Clinical Study of Histidine Supplementation for Antitumor Immunity in Colorectal Cancer

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2026-05-06

Completion Date

2027-06

Last Updated

2026-08-20

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Histidine

Histidine capsules, 1000 mg per capsule, taken orally as 2 capsules once daily for 9 weeks. Histidine supplementation will be administered in addition to standard anti-tumor treatment determined by the treating physician according to clinical guidelines.

Locations (1)

Shanghai Punan Hospital of Pudong New District

Shanghai, Shanghai Municipality, China